Durvalumab (D) +/- tremelimumab (T) plus platinum-etoposide (EP) in 1L extensive-stage (ES) SCLC: characteristics of long-term survivors in the CASPIAN studyJonathan W. Goldman,Marina Chiara Garassino,Yuanbin Chen,Katsuyuki Hotta,Artem Poltoratskiy,Maximilian J. Hochmair,Mustafa Ozguroglu,Jun Ho Ji,Galina Statsenko,Oleksandr Voitko,Nikolay V. Conev,Igor Bondarenko,Helen Mann,Mingchao Xie,Yashaswi Shrestha,Priti Chugh,Tapashi Dalvi, Luis Paz-Ares,Helge BischoffANNALS OF ONCOLOGY（2022）引用 2|浏览15暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
